Joseph C Papa is Director of Prometheus Biosciences, Inc.. Currently has a direct ownership of 0 shares of RXDX, which is worth approximately $0. The most recent transaction as insider was on Jun 16, 2023, when has been sold 7,278 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

JOSEPH C PAPA Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2023
SELL
Sale (or disposition) back to the issuer
-
7,278 Reduced 100.0%
0 Common Stock
Jun 02 2023
SELL
Other acquisition or disposition
-
10,000 Reduced 57.88%
7,278 Common Stock
May 19 2023
BUY
Grant, award, or other acquisition
-
2,278 Added 11.65%
17,278 Common Stock
Mar 16 2021
BUY
Open market or private purchase
$285,000 $19.0 p/Share
15,000 Added 50.0%
15,000 Common Stock

Also insider at

BHC
Bausch Health Companies Inc. Healthcare
BLCO
Bausch & Lomb Corp Healthcare
CADL
Candel Therapeutics, Inc. Healthcare
EBS
Emergent BioSolutions Inc. Healthcare
MIST
Milestone Pharmaceuticals Inc. Healthcare
JCP

Joseph C Papa

Director
Needham, MA

Track Institutional and Insider Activities on RXDX

Follow Prometheus Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXDX shares.

Notify only if

Insider Trading

Get notified when an Prometheus Biosciences, Inc. insider buys or sells RXDX shares.

Notify only if

News

Receive news related to Prometheus Biosciences, Inc.

Track Activities on RXDX